Agoracom Blog Home

Posts Tagged ‘CSE’

Binovi $VISN.ca $BNVIF Appoints Dr. Michael Gallaway to the Binovi Scientific Advisory Board $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 10:23 AM on Tuesday, December 22nd, 2020
  • Announced the appointment of Dr. Michael Gallaway to the Binovi Scientific Advisory Board. Dr. Galloway joins the other members of the board in directing the company’s advancements.
  • “We are very pleased to welcome Dr. Gallaway to the Scientific Advisory Board. His extensive experience working with children will help tremendously as we push Binovi into the education sector, with our focus on K-12 -and particularly K-3-students,” said Adam Cegielski, Binovi CEO.

TORONTO, ON and NEW YORK, NY / December 22, 2020 / Binovi Technologies Corp., (Binovi) (OTCQB:BNVIF) (TSX-V:VISN) (GR:2EYA) is proud to announce the appointment of Dr. Michael Gallaway to the Binovi Scientific Advisory Board. Dr. Galloway joins the other members of the board in directing the company’s advancements.

“We are very pleased to welcome Dr. Gallaway to the Scientific Advisory Board. His extensive experience working with children will help tremendously as we push Binovi into the education sector, with our focus on K-12 -and particularly K-3-students,” said Adam Cegielski, Binovi CEO.

“I am delighted that Dr. Gallaway has joined our Scientific Advisory Board”, commented Dr. Leonard Press, Binovi Chief Scientific Officer. “His background in scientific research, vision-based learning problems, vision screening, and concussion management, will help take Binovi to another level.”

“I look forward to joining Binovi’s Scientific Advisory Board especially as the company is targeting more advanced school screening protocols and interventions for children,” said Dr. Gallaway, Binovi Scientific Advisory Board Member.

About Dr. Michael Gallaway

Dr. Gallaway is board certified in vision therapy as a Fellow in the College of Optometrists in Vision Development (COVD), and is a Fellow in the American Academy of Optometry (AAO). He has been in private practice in the South Jersey area since 1989, specializing in vision therapy and children’s vision disorders. He is also an Associate Professor at the Pennsylvania College of Optometry at Salus University in Philadelphia. In addition to his teaching, he is involved in research in learning related vision problems, amblyopia, vision therapy for convergence insufficiency, and concussion-related vision problems. He has published many articles in optometric journals and has lectured extensively in the US and internationally on children’s vision and vision therapy.

Dr. Gallaway was the Principal Investigator at Salus/PCO for CITT-ART, a National Eye Institute funded nationwide study assessing the impact of vision therapy for convergence insufficiency on reading and attention. In 2015, Dr. Gallaway received the Skeffington Award for Excellence in Optometric Writing from the College of Optometrists in Vision Development in recognition of his scholarly writing and research over his career. Dr. Gallaway was also the Principal Investigator at Salus University for the Convergence Insufficiency Treatment Trial (CITT), an NIH funded randomized multicenter clinical trial that was published in 2008.

Dr. Gallaway was also an Investigator both in his office and at Salus University for the Pediatric Eye Disease Investigator Group (PEDIG) studying the Amblyopia Treatment Studies, which Dr. Gallaway has participated in from 2001 to 2019.

For additional information on the Company, please visit https://www.binovi.com/binovi-connect

@BinoviVISN – Twitter & Instagram

About Binovi Connect

Binovi is digitizing the delivery of healthcare by providing users access to all points of their individual performance from their phone, tablet or desktop computer. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. As a SAAS based solution, the Binovi Connect App is supported by specialized expert knowledge, unique data insights and supporting hardware to deliver customized, one-on-one cognitive training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Binovi is currently used in over 20 countries.

Terry Booth
Executive Chairman

Adam Cegielski
Founder | CEO

Dr. Leonard Press
Chief Scientific Officer

Investor Relations

Email: [email protected]
Toll-free: 1 (844) 866-6162
https://www.binovi.com/investor-reports/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Binovi Technologies Corp.

PlantX $VEGA.ca $PLTXF to begin trading on the OTCQB Venture Market

Posted by AGORACOM-JC at 9:09 AM on Tuesday, December 22nd, 2020
PlantX | LinkedIn
  • Announced that its common shares will commence trading on the OTCQB ® Venture Market in the United States under the symbol “PLTXF” effective December 22, 2020 .
  • The OTCQB Venture Market is for early-stage and developing companies. In order to be eligible, companies must be current in their financial reporting, pass a minimum bid price test and undergo an annual company verification and management certification process.
  • The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.

VANCOUVER, BC , Dec. 22, 2020 – PlantX Life Inc. (the ” Company ” or ” PlantX “) (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF) is pleased to announce that its common shares will commence trading on the OTCQB ® Venture Market in the United States under the symbol “PLTXF” effective December 22, 2020 .

The OTCQB Venture Market is for early-stage and developing companies. In order to be eligible, companies must be current in their financial reporting, pass a minimum bid price test and undergo an annual company verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.

PlantX continues to advance its plans to open its first brick and mortar locations in San Diego, California and Squamish, British Columbia , with plans of future franchising across North America . PlantX will also continue to expand its e-commerce capabilities around the world with new and exciting partnerships, acquisitions and verticals in the plant-based industry.

The Company’s digital platforms PlantX.com and PlantX.ca currently make available thousands of plant-based products from top brands in the industry, offer indoor plant delivery, a restaurant locator, weekly-curated plant-based recipes, news articles and blogs. PlantX also recently announced its newly-formed Medical Advisory Board comprised of medical professionals from around the world to guide and support the Company’s products, recipes and educational offerings with medical and scientific expertise.

“The addition of another trading platform will continue to increase PlantX’s visibility with investors,” said Sean Dollinger , PlantX founder. “We as a company know plant-based living is the future, and it’s great that our investors and shareholders will be able to share in that excitement.”

PlantX’s shares will continue to trade on the Canadian Securities Exchange (CSE) under its existing symbol “VEGA” and the Frankfurt Exchange under the symbol “WNT1”.

The Company website is http://investor.PlantX.com/ .

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing, and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes, without limitation, statements regarding the commencement of the trading of the Company’s common shares on the OTCQB Venture Market, the expansion of the Company’s e-commerce capabilities, the opening of the Company’s new brick and mortar locations in San Diego, CA and Squamish, B.C and the business and strategic plans of the Company.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.

Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

New Age Metals $NAM.ca $NMTLF Corporate Update – Year in Review & Outlook for 2021 $LIX.ca $LI.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 8:59 AM on Tuesday, December 22nd, 2020
http://www.smallcapepicenter.com/NAM%20square.png
  • In 2020 the Company’s primary objective was to follow up on recommendations made in the 2019 River Valley Palladium Project Preliminary Economic Assessment (PEA).
  • The River Valley Palladium Project is one of North America’s largest undeveloped primary Platinum Group Metal (PGM) projects. The Project has excellent infrastructure and is within 100 kilometres of the Sudbury Metallurgical Complex. The Project is 100% owned by New Age Metals.
  • The Company completed a three-phase exploration and development plan at River Valley which included drilling, environmental, and archaeological studies.
  • The Company also completed follow-up mapping and sampling programs on its Lithium One Project in Southeast Manitoba. The program was co-funded by the Manitoba Chamber of Commerce’s, Manitoba Mineral Development Fund (MMDF). In December the Company received a drill permit for its Lithium Two Project and a permit is pending for Lithium One. Further drill target definition surveys are being contemplated for 2021.
  • The Company is expecting results and corresponding press releases from both its rhodium evaluation program at River Valley and the surface sampling program from its Lithium One Project in Manitoba before the end of January 2021.
  • The spot price of an ounce of Palladium increased by over 18% in the last year, to $US2,220/oz as at December 21, 2020. Rhodium, which is also present at River Valley, has seen a price increase of over 160% year-to-date to $US16,000/ oz.
  • The Company is actively seeking an option/joint venture partner for our Genesis PGM-Cu-Ni Project in Alaska and for our Lithium division in Manitoba.

December 22, 2020 – Rockport, Canada – New Age Metals Inc. (TSXV:NAM ) | ( OTC:NMTLF ) | ( FSE:P7J) Harry Barr, Chairman & CEO, stated ; “We are pleased to provide shareholders with a year end review of our activities in 2020 and a view of our exploration and development plans for our portfolio of green metal projects in 2021.”

The Company’s primary objective this year was to follow-up on recommendations made in the 2019 River Valley Project PEA. To that end we have completed a three-phase exploration and development plan which included two rounds of drilling, initiated environmental baseline and archaeological studies, and have commenced a phase one rhodium evaluation program with the objective of including rhodium as a payable metal.

As we progress into 2021, we are focused on advancing River Valley to a Prefeasibility study. This would include recommendations to complete metallurgy, hydrogeology, geotechnical surveys, an updated mineral resource estimate, environmental baseline, infill and exploration drilling. Management is currently soliciting quotes from third party engineering firms with the objective of completing a final Prefeasibility budget by the end of February 2021. Subject to the completion of additional funding we plan to initiate this study by the third quarter of 2021 and our objective is to complete the Prefeasibility study by the end of the first quarter of 2022.

Genesis PGM-Cu-Ni Project

The Genesis PGM-Cu-Ni Project is an under explored, highly prospective drill ready property. In 2020 NAM’s management continued to seek an option/joint-venture partner for this road accessible PGM-Cu-Ni Project using the Prospector Generator business model. COVID-19 disrupted property visits which in turn hindered any finalization of a potential option / joint venture deal. The Company paid for all holding costs in 2020 and the project remains in good standing. The stable land status, ease of access and superb infrastructure make this project prospective for year-around exploration, and development.

2020 Exploration and 2021 Plans for Lithium Division

The Company has several Lithium and Rare Element Projects in the Winnipeg River Pegmatite Field, located in South East Manitoba and situated around the Tanco Mine. The world-class Tanco Pegmatite is a highly fractionated lithium-cesium-tantalum (LCT)–type pegmatite that has historically been mined (Tanco Mine) since 1969 for Li, Ta, Cs, Rb and Be ores. The Tanco Pegmatite is a very rich tantalum and cesium deposit with it being the world’s most significant and richest known source of cesium representing more than two-thirds of the world’s reserve.

In 2020, the company conducted a follow-up round of surface exploration work on its Lithium One Project to generate future drill targets. This program was co-funded by a grant from Manitoba Chamber of Commerce’s, Manitoba Mineral Development Fund (MMDF). Over 80 samples have been sent to a laboratory in Saskatchewan and results are expected in January. Samples from a previous work program on the project were taken from the Silverleaf and Annie pegmatites and not only returned significant Li20 assays of up to 4.1% but heightened levels of Rubidium Oxide (Rb2O).

Management plans to make a second application for a grant from the MMDF in 2021. In December 2020 the Company received a drill permit for its Lithium Two Project and the application for a permit on Lithium One was submitted to the Manitoba government. The Company continues to solicit potential option/joint venture partner(s) to continue the development of its Lithium division.

Shares for Services

The Company has issued 135,600 common shares at a deemed value of $0.10 per share to Agora Internet Relations Corp. (“AGORACOM”) pursuant to the terms of the March 2020 agreement. The securities issued represent the fourth payment for services under the terms of the agreement and are subject to a four month plus one day hold period expiring April 22, 2021.

Opt-in List

If you have not done so already, we encourage you to sign up on our website ( www.newagemetals.com ) to receive our updated news.

About NAM

New Age Metals is a junior mineral exploration and development company focused on the discovery, exploration and development of green metal projects in North America. The Company has two divisions; a Platinum Group Metals division and a Lithium/Rare Element division. The PGM division includes the 100% owned, multi-million-ounce, district scale River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 km from Sudbury, Ontario. The Company has recently completed a Preliminary Economic Assessment on the project and is working towards Prefeasibility. In Alaska the Company owns 100% of the Genesis PGM-Cu-Ni Project.

The Lithium division is the largest mineral claim holder in the Winnipeg River Pegmatite Field, where the Company is exploring for hard rock lithium and various rare elements such as tantalum and rubidium.  Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production. The Company is actively seeking an option/ joint venture partner for its road-accessible Genesis PGM-Cu-Ni project in Alaska and for our Lithium division in Manitoba.

Investors are invited to visit the New Age Metals website at www.newagemetals.com where they can review the company and its corporate activities. Any questions or comments can be directed to [email protected] or Harry Barr at [email protected] or Cody Hunt at [email protected] or call 613 659 2773.

On behalf of the Board of Directors

Harry Barr”

Harry G. Barr

Chairman and CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties.  These statements may differ materially from actual future events or results and are based on current expectations or beliefs.  For this purpose, statements of historical fact may be deemed to be forward-looking statements.  In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions.  These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements.  The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.  Investors should not place undue reliance on forward-looking statements.

$KABN.ca North America Announces Closing of $3 Million Non-Brokered Private Placement $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 8:11 AM on Tuesday, December 22nd, 2020
kabn-square-new
  • Announced that it has closed its Non-Brokered Private Placement of units for gross proceeds of approximately $3 Million previously announced on December 10, 2020.
  • A total of 19,999,997 Units were issued at a purchase price of $0.15 per Unit, with each Unit comprised of one common share of the Company and one Common Share purchase warrant
  • Each Warrant is exercisable to acquire one Common Share at an exercise price of $0.20 per Warrant Share for a period of 24 months from the closing.

TORONTO, ON / December 22, 2020 / KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN North America” or “KABN NA“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has closed its Non-Brokered Private Placement of units (“Units“) for gross proceeds of approximately $3 Million (the “Non-Brokered Offering“) previously announced on December 10, 2020. A total of 19,999,997 Units were issued at a purchase price of $0.15 per Unit, with each Unit comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant is exercisable to acquire one Common Share (a “Warrant Share“) at an exercise price of $0.20 per Warrant Share for a period of 24 months from the closing. The Units will have a hold period of four months and one day from the applicable closing.

“We are pleased to welcome a number of new investors and financial services firms as Company shareholders. The interest in the offering was in excess of the available units, even after the increase in the offering from $2 Million to $3 Million,” said David Lucatch, CEO. “We would also like to welcome Mr. Rob Anson, CEO of Loop Insights Inc., and Mr. Sheldon Inwentash, Founder, Chairman and CEO of ThreeD Capital, both as new investors in KABN NA and as members of our Industry Advisory Committee to support the Company with its future growth.”

In connection with the Non-Brokered Offering, the Company paid finder’s fee in the aggregate sum of $130,620 and issued 990,800 compensation options (the “Finders’ Options“) to certain eligible finders. Each Finders’ Option entitles the holder to purchase one Unit at an exercise price equal to C$0.15 per Unit at any time up to 24 months following closing.

The Company’s previously announced brokered private placement of up to $1.15 Million is expected to close on or about December 29, 2020, or on such earlier date as agreed upon between the Company and the agent, and is subject to certain conditions, including receipt of subscription agreements and payment of the subscription amounts by subscribers.

The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.

Update on Family Office Financing
With respect to the US-led Family Office financing originally announced on August 18, 2020, with subsequent updates made on September 16, and October 22, 2020, the subscribers have failed to date to fund their commitments. On December 8, 2020, the Company delivered demand letters to the subscribers, demanding that they close by December 11, 2020. Having failed to do so, the Company views these agreements as being at an end, and has demanded that the subscribers reimburse the Company for the costs it has incurred in respect of these subscriptions. The Company is reserving its rights to take further action in the future.

About KABN North America – www.kabnnaholdco.com
KABN Systems NA Holdings Corp. through its wholly-owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from the use of their online identity. KABN NA’s propriety technology suite includes 4 key products:

Liquid Avatar allows users to create high-quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allow users to manage and control their Self Sovereign Identity and to use Liquid Avatars to share verifiable credentials, including access, identity and designation credentials, and public and permission-based private data when they want and with whom they want. www.liquidavatar.com

KABN ID is an Always On, biometric and blockchain-based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com

KABN KASH is a cashback, loyalty and engagement program that powers the KABN NA’s revenue ecosystem. KABN NA provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

KABN Systems NA Holding Corp. is a publicly listed company listed on the Canadian Securities Exchange under the symbol “KABN”.

For further information, please contact:
David Lucatch
647-725-7742 Ext. 701
[email protected]

Hollister Biosciences Inc.’s $HOLL.ca $HSTRF Direct to Consumer #Cannabis Delivery Platform, Dreamy Delivery Launches 2nd Depot in Sacramento, California $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca $ALID

Posted by AGORACOM-JC at 7:41 AM on Tuesday, December 22nd, 2020
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1
  • Announced the launch of its 2nd fulfillment depot for its direct-to-consumer cannabis delivery platform, Dreamy Delivery
  • Company soft launched Dreamy Delivery to friends and family in the San Francisco Bay Area of Northern California , to ensure a seamless customer experience in early Q4 of 2020.
  • The Company has expanded the Platform, with Dreamy now successfully delivering to legal cannabis consumers in the San Francisco Bay Area of Northern California and now Sacramento , California.

VANCOUVER, BC , Dec. 22, 2020 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the ” Company “, ” Hollister Cannabis Co. ” or ” Hollister “) a diversified cannabis branding company with products in over 280 dispensaries throughout California , and over 80 dispensaries throughout Arizona , is pleased to announce the launch of its 2nd fulfillment depot for its direct-to-consumer cannabis delivery platform, Dreamy Delivery (” Dreamy ” or the ” Platform “).

The Company soft launched Dreamy Delivery to friends and family in the San Francisco Bay Area of Northern California , to ensure a seamless customer experience in early Q4 of 2020. The Company has expanded the Platform, with Dreamy now successfully delivering to legal cannabis consumers in the San Francisco Bay Area of Northern California and now Sacramento , California. The Company hopes to launch Dreamy in the Central Coast of California by early Q1 of 2021 with the ultimate goal of delivering Cannabis statewide.

Carl Saling , CEO of Hollister , shared, “Very excited to have opened our 2nd direct to consumer delivery depot in record time, allowing us to serve legal adults in the Sacramento Area . This furthers our quest to be a dominate direct to consumer delivery platform in California .”

Website: www.dreamydelivery.com

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com .

VIDEO – Empower Clinics $CBDT.ca $EPWCF CEO Says 2021 Will Be A Big Year With ~ $6.8M In Cash, New Acquisition, Partnerships and Products $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 10:26 PM on Monday, December 21st, 2020

Sometimes, you just have to let the numbers speak for themselves.  With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that any small cap Health & Wellness company  would kill for … but then you add in that CBDT has now delivered growth in 5 (FIVE) successive financial reports (Q4, FY 2019, Q1, Q2 and Q3), so it is safe to say that superstar CEO Steve McAuley can officially claim victory on the turnaround he inherited in 2019.

But he was far from done.

On November 13th Empower announced it’s newly acquired Kai Medical Laboratory Achieved Record Testing Volume Month in October and Has Already Signed Numerous New Contracts … and that was the day the markets finally discovered what we already knew.  Empower Clinics was a major player in the Health & Wellness space from the lab to the clinic.

But he was far from done.

Since that day Empower has made several announcements that grew the Company by several magnitudes again.  From record testing contracts to new products, partnerships (We see you Loop Insights $MTRX + SimpliFlying) and a $5.5 MILLION injection from warrant proceeds (that is now closer to $6.8M), McAuley was building the foundations of a health & wellness powerhouse.

And let’s not forget about the major acquisition of 7 Canadian clinics with an immediate plan to add another 30 clinics across the country with some potential major partners/

Finally, for all the new investors that have joined Empower in the last several weeks, McAuley is Six Sigma certified under the quality initiative of legendary GE (General Electric) Chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which explains how McAuley has been able to guide Empower Clinics through the most disruptive environment in recent history and turn it into significant growth through Q4 2020 and the foundations to turn it into a powerhouse over the next 3 years. 

If you MISSED Well Health and CloudMD, you really need to take a close look at Empower as the next great potential small cap health & wellness company.

Watch this amazing interview.

VIDEO – ThreeD Capital $IDK.ca $IDKFF Hits Another 52 Week High And 610% YTD As Investors Discover Sheldon Inwentash and IDK Are The Common Denominator On Many Big Small Cap Winners $PKK.ca $PKKFF $MTRX.ca $RACMF $HPQ.ca

Posted by AGORACOM-JC at 7:06 PM on Monday, December 21st, 2020
IDK-square-for-blog

ThreeD Capital (IDK:CSE / IDKFF:OTCQB) prides itself on discovering great companies before everyone else … and so do shareholders who are being rewarded with another 52 week high thanks to Chairman and CEO Sheldon Inwentash, who is showing once again that he can find and invest in great “Ignored and undervalued companies” on his way to a 610% gain for IDK Year To Date.

He may make it look easy but Inwentash tirelessly casts a wide net 24/7/365 (trust us, we know) in his favourite industries to find best of breed companies in either Disruptive Technologies or Junior Resources.  And when he finds them, he isn’t afraid to have IDK invest big and be patient, something most investors just aren’t willing to do when they’re fixated on just daily or even hourly moves.

That’s why IDK, is like and ETF for ground floor investments that small cap investors would either be unable to find (private) or unable to participate in (early round accredited investors) or unable to hold.

For new investors to the markets in 2021 who don’t know him but better get to know him ASAP, Sheldon Inwentash is one of the greatest investors in Canadian history.  As Founder, Chairman and CEO of IDK, Inwentash’s track record of success speaks for itself, including successful exits in the hundreds of millions and even billions of dollars in previous years.  His last investment company commanded a market cap north of $1 Billion and now he’s looking to create another success with IDK.  

Will he do it?  He’s sure off to a good start so far by quietly making investments over the past couple of years that are now starting to pay off.  In this interview Inwentash discusses:

  • His investment philosophy
  • Some of his big 2020 winners including 
    • Peak Fintech $PKK – $PKKFF 
    • Loop Insights $MTRX – $RACMF
    • HPQ Silicon $HPQ
    • Esports Entertainment Group $GMBL
    • Bluesky Digital $BTC
    • ImagineAR $IP $IPNFF – where he is re-accumulating again
  • Why he’s investing heavily in gold juniors
  • Why he’s investing heavily in crypto currencies
  • Best of all, after one hell of a ride for the financial markets in 2020, Inwentash talks about why 2021 “is the year to be all in”

Watch this great interview … because when a legendary financier speaks, every small cap investor should be listening. We know we do.

Blockchain Foundry $BCFN.ca Announces Phase 2 Blockchain Development Agreement with GDPR Compliance Solution Provider $HUT.ca $BITF.ca $GLXY.ca $HIVE.ca $VYGR.ca

Posted by AGORACOM-JC at 9:24 AM on Monday, December 21st, 2020
http://blog.agoracom.com/wp-content/uploads/2020/10/blockchain-foundry-square.png
  • Entered into the second phase of a blockchain development agreement with a client in the General Data Protection Regulation compliance space
  • This phase of the Agreement is valued at approximately $60,000 and will last for approximately seven weeks.
  • The prior, initial phase of the Agreement was valued at approximately $50,000 and has now been completed.
  • Client expects to undertake more product development beyond the MVP phase and BCF will have the opportunity to establish itself as the preferred vendor for future development initiatives.

TORONTO, Dec. 21, 2020 – Blockchain Foundry Inc. (“BCF” or the “Company”) (CSE:BCFN), a leading North American blockchain development firm, has entered into the second phase of a blockchain development agreement (the “Agreement”) with a client (the “Client”) in the General Data Protection Regulation (“GDPR”) compliance space. This phase of the Agreement is valued at approximately $60,000 and will last for approximately seven weeks. The prior, initial phase of the Agreement was valued at approximately $50,000 and has now been completed. For more information on the initial engagement please refer to the Company’s press release dated October 5, 2020.

GDPR is a regulation in EU law concerning data protection and privacy. The market for GDPR compliance services in Europe is estimated to be worth approximately US$1.2 billion by 2023 1 .

Pursuant to the Agreement, BCF will work with the Client to complete the MVP of its GDPR compliance solution. The Client expects to undertake more product development beyond the MVP phase and BCF will have the opportunity to establish itself as the preferred vendor for future development initiatives.

About Blockchain Foundry Inc.

Blockchain Foundry develops and commercializes blockchain-based business solutions and provides consulting services to corporate clients seeking to incorporate blockchain technology into their businesses.

Blockchain Foundry Contact Information:

Chris Marsh
President
[email protected]
(647) 330-4572

Forward-Looking Information

Certain portions of this press release contain “forward-looking information” within the meaning of applicable Canadian securities legislation, which is also referred to as “forward-looking statements”, which may not be based on historical fact. Wherever possible, words such as “will”, “plans,” “expects,” “targets,” “continues”, “estimates,” “scheduled,” “anticipates,” “believes,” “intends,” “may,” “could,” “would” or might, and the negative of such expressions or statements that certain actions, events or results “may,” “could,” “would,” “might” or “will” be taken, occur or be achieved, have been used to identify forward-looking information.

Forward-looking statements should not be read as guarantees of future events, future performance or results, and will not necessarily be accurate indicators of the times at, or by which, such events, performance or results will be achieved, if achieved at all. Readers should not place undue reliance on such forward-looking statements, as they reflect management’s current views with respect to future events and are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BCF are inherently subject to significant business, economic, regulatory, competitive, political and social uncertainties, and contingencies. Many factors could cause BCF’s actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements.

Harborside Inc.$HBOR.ca Completes Acquisition of San Francisco Dispensary $HBOR.ca $VFF.to $HARV.ca $ACB.to

Posted by AGORACOM at 8:48 AM on Monday, December 21st, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564690/hub/Harborside_Inc2_logo.png
  • Expands Footprint with Social Equity Dispensary in Historic Haight-Ashbury District 

Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR), (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, announces the closing of the transactions contemplated by the previously announced agreement to acquire 50.1% of the equity (the “Shares”) of FGW Haight, Inc. (“FGW”), a California corporation which has the conditional use approval necessary to operate a cannabis dispensary and related businesses in the Haight Ashbury area of San Francisco, California (the “Acquisition”).

With the completion of the Acquisition, Harborside expands its retail dispensary footprint in the state of California to five and solidifies a strong presence in the historic and culturally-significant Haight-Ashbury district of San Francisco. The Company expects to complete the build-out, receive all necessary regulatory approvals, and open the social equity retail dispensary in the third quarter of 2021.

“I’m excited to continue to expand our footprint in California and look forward to serving consumers in Haight Ashbury,” said Peter Bilodeau, Interim CEO of Harborside. “Together, we will work with the team from FGW to give back to the community and support initiatives to address the negative impact of past cannabis policies which have disproportionally impacted low income and minority community members. This new location will also introduce the best-in-class service and unbeatable product selection that Harborside has become famous for to an iconic area of San Francisco.”

Upon closing of the Acquisition, Harborside paid an aggregate purchase price of USD $2,179,350 based on a post-build-out and proforma working capital enterprise value of USD $4,350,000 (the “Purchase Price”). The Purchase Price is comprised of: (a) USD $1,265,000 as consideration for convertible notes of FGW entitling the Company to such number of underlying Shares equal to 29.1% of the Shares; and (b) the balance of the Purchase Price in multiple voting shares (“MVS”) valued at CAD$125 per MVS as consideration to certain selling shareholders of FGW for 21% of the issued and outstanding Shares.

Subject to regulatory approval, Harborside has also agreed to purchase an additional 29.9% of the issued and outstanding Shares (the “Subsequent Shares”) to get to an 80% ownership of FGW, subject to regulatory approvals. The aggregate purchase price for the Subsequent Shares will be USD $1,300,650, which will be satisfied in MVS valued at the greater of: (i) the 30 day VWAP of the subordinate voting shares of the Company on the Canadian Securities Exchange (“CSE”) at the time of issuance less a discount multiplied by 100; (ii) CAD$150 per MVS; or (iii) such other price as may be approved by the CSE. Harborside also retains the right of first refusal to purchase, in its discretion, in whole or in part and in one or more closings, the remaining 20% of the Shares, subject to regulatory approvals.

About Harborside:
Harborside Inc. is one of the oldest and most respected cannabis retailers in California, operating three of the major dispensaries in the San Francisco Bay Area, a dispensary in the Palm Springs area outfitted with Southern California’s only cannabis drive-thru window, a dispensary in Oregon and a cultivation/production facility in Salinas, California. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the CSE trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at www.sedar.com.

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564690/hub/Harborside_Inc2_logo.png

Cardiologists to Use the HeartCheck(TM) #CardiBeat With #ECG Triaging Services for Remote Patient ECG Monitoring – CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 7:25 AM on Monday, December 21st, 2020

Patient Self-Monitoring Extends Physicians’ Reach for Monitoring During COVID-19

  • Confirms the start of an out-of-office ECG monitoring program using the HeartCheck™ CardiBeat Handheld ECG monitor, the GEMS™ Mobile RPM Smartphone app and the SMART Monitoring ECG triaging service to support prescribed in-home arrhythmia monitoring.
  • Heart Health Institute, a large arrhythmia practice network located in the Greater Toronto Area, will be recommending the HeartCheck™ CardiBeat to their cardiac patients for up to six months of in-home, arrhythmia self-monitoring use with an emphasis on detecting a recurrence of atrial fibrillation and supraventricular tachycardia.

TORONTO, ON / December 20, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) (“CardioComm” or the “Company“), a global provider of consumer heart monitoring and electrocardiogram (“ECG“) device and software solutions, confirms the start of an out-of-office ECG monitoring program using the HeartCheck™ CardiBeat Handheld ECG monitor, the GEMS™ Mobile RPM Smartphone app and the SMART Monitoring ECG triaging service to support prescribed in-home arrhythmia monitoring.

The Heart Health Institute (“HHI“), a large arrhythmia practice network located in the Greater Toronto Area (Ontario, Canada), will be recommending the HeartCheck™ CardiBeat to their cardiac patients for up to six months of in-home, arrhythmia self-monitoring use with an emphasis on detecting a recurrence of atrial fibrillation and supraventricular tachycardia.

CardioComm’s GEMS™ Mobile Smartphone app supports physician and research-based remote patient monitoring (“RPM“) requirements including providing rapid ECG reporting directly to the prescribing physician’s electronic medical records as patient triggered ECGs are taken. ECGs recorded by HHI patients using the GEMS™ Mobile RPM Smartphone app and the HeartCheck™ CardiBeat be rapidly triaged by CardioComm’s SMART Monitoring ECG service to detect for the presence of any number of arrhythmias. Any submitted ECG recordings that show a presence of a cardiac arrhythmia will be flagged so that HHI patients may be contacted and a follow-up visit scheduled. ECG reports generated through GEMS™ Mobile are eligible for medical service reimbursement in both Canada and the US.

Physicians at HHI intend to introduce the use of the HeartCheck™ ECG/arrhythmia monitoring technology to patients with difficult to capture arrhythmias and to reduce clinical workload in dealing with COVID-19 precautions. Due to COVID-19, patients are reluctant to visit their physician for cardiac testing and some pratices have also implemented new protocols that have made it more challenging to see their patients.

Under the GEMS™ Mobile RPM model, patients will be able to purchase the HeartCheck™ CardiBeat directly through the HHI offices or on-line directly from CardioComm with an HHI physician referral. ECG reporting will be made available at no cost to the patients over a six month monitoring period or until a diagnosis has been made. Following completion of the HHI monitoring period, patients will be able to continue to use the wireless HeartCheck™ CardiBeat ECG device and GEMS™ Mobile app under the Company’s consumer use model.

The GEMS™ Mobile RPM app is available in Android and Apple Smartphone compatible versions as a free downloadable app and allows users to generate ECG reports to show to their physician. The app also allows users to request their ECG to be reviewed by CardioComm’s SMART Monitoring ECG reading service where the user does not have direct connectivity to their treating physician.

To learn more about CardioComm’s products and for further updates regarding HeartCheck™ ECG device RPM use by healthcare professionals please visit the Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com.

About CardioComm Solutions

CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485:2016 MDSAP certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).

FOR FURTHER INFORMATION PLEASE CONTACT:

Etienne Grima, Chief Executive Officer
1-877-977-9425 x227
[email protected]
[email protected]

Forward-looking statements

This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: CardioComm Solutions, Inc